Pharmaceuticals, Biotechnology and Life Sciences
— OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients — SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ:…
– Pivotal Phase 3 Findings Support the Potential of a Novel Single-Tablet Combination of Bictegravir and Lenacapavir for HIV Treatment…
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration (FDA) has approved its…
Nationally recognized public health leader and former Director of the CDC to provide strategic guidance on GX-03 development, the Company’s…
Milestone achieved in Scribe and Lilly’s ongoing collaboration to develop in vivo CRISPR-based therapeutics for neurological and neuromuscular diseases Achievement…
Appointment strengthens Artis platform strategy in nucleic acid medicines in connection with pending Syngoi acquisition SAN DIEGO–(BUSINESS WIRE)–Artis BioSolutions today…
—Industry veteran brings global regulatory expertise to support development of innovative optogenetic gene therapies— BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics, a clinical-stage…
– Data Support the Study of RLYB116 as a Potential Best-In-Class Therapeutic for Multiple Complement Mediated Diseases – – Initiation…
New research findings to be presented at Digestive Disease Week 2026 demonstrate that NIM-1324 outperforms current IBD medications and establish…
First-in-human data for long-acting formulations of VH184, the first third-generation integrase inhibitor, and early data for capsid inhibitor VH499 to…